Heron Therapeutics, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
HRTX Company Description
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
HRTX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view HRTX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of HRTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HRTX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of HRTX in WallStreetBets Daily Discussion
HRTX News
Recent insights relating to HRTX
CNBC Recommendations
Recent picks made for HRTX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in HRTX
Corporate Flights
Flights by private jets registered to HRTX
Our Analysis